Capability details
TransGenRx has developed technology that significantly reduces the cost of producing protein-based drugs by using a high expressing avian cell line combined with their patented vector system. Patented and patent pending processes allow TGRx to develop custom proteins to meet a wide range of specifications. Use the links on the left to learn more about our team as well as our products and services we offer.